Hanna Rahbek Mortensen

Associate Professor

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hanna Rahbek Mortensen is an Associate Professor at Aarhus University in Denmark. Her research focuses on radiotherapy quality assurance, particularly in the context of clinical trials and treatment protocols for cancers such as esophageal and hepatocellular carcinoma. Recent contributions include developing guidelines for the diagnosis and treatment of oligometastatic esophagogastric cancer and evaluating the use of proton versus photon therapy.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (20)

Anne Petas Swane Krarup

Aalborg University

DENMARK

Hanna Rahbek Mortensen

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Recommendations for radiotherapy quality assurance in clinical trials

An interactive deep-learning workflow for head and neck gross tumour volume segmentation

Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer

European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)

Recent update of proton beam therapy for hepatocellular carcinoma: A systematic review and meta-analysis

Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648

Defining dysphagia – a modified multi-professional Danish Delphi study

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe.

Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients

Intrafraction tumor motion monitoring and dose reconstruction for liver pencil beam scanning proton therapy

Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres

Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer

Clinical outcomes after stereotactic ablative radiotherapy in locally advanced cholangiocarcinoma

Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations

Collaborators (20)

Anne Petas Swane Krarup

Elke Van Daele

Jasper Nijkamp

Hanneke W. M. van Laarhoven

Mads brincker

Sun Hyun Bae

Jesper Folsted Kallehauge

Eva Samsøe

Francesca Fiorini

Alessio Giuseppe Morganti

Camiel Rosman

Jenny Bertholet

Won Il Jang

Ditte Sloth Møller

Morten Høyer

L. Hoffmann

Anne Højager Nielsen

Anna Dorothea Wagner

Per Rugaard Poulsen

Per Pfeiffer

Make your next move.